Health CanadaGeneral Alert
Archived - New CONTRAINDICATION regarding ergotamine- and dihydroergotamine-containing drugs: Risk of Cerebral and/or Peripheral Ischemia - Novartis Pharmaceuticals Canada Inc
Published: January 30, 2003Recall ID: 24481Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
Archived - New CONTRAINDICATION regarding ergotamine- and dihydroergotamine-containing drugs: Risk of Cerebral and/or Peripheral Ischemia - Novartis Pharmaceuticals Canada Inc
Recalling Firm: Marketed health products
Product Description & Identification
Archived - New CONTRAINDICATION regarding ergotamine- and dihydroergotamine-containing drugs: Risk of Cerebral and/or Peripheral Ischemia - Novartis Pharmaceuticals Canada Inc
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24481 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/archived-new-contraindication-regarding-ergotamine-and-dihydroergotamine-containing |
| Title | Archived - New CONTRAINDICATION regarding ergotamine- and dihydroergotamine-containing drugs: Risk of Cerebral and/or Peripheral Ischemia - Novartis Pharmaceuticals Canada Inc |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2003-01-30 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - Archived - New CONTRAINDICATION regarding ergotamine- and dihydroergotamine-containing drugs: Risk of Cerebral and/or Peripheral Ischemia - Novartis Pharmaceuticals Canada Inc Check if your household is affected: https://therecallfile.com/recalls/archived-new-contraindication-regarding-ergotamine-and-dihydroergotami/CANADA-24481
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordArchived - New CONTRAINDICATION regarding ergotamine- and dihydroergotamine-containing drugs: Risk of Cerebral and/or Peripheral Ischemia - Novartis Pharmaceuticals Canada Inc